PathMaker Neurosystems is a clinical stage neuromodulation company applying a fundamentally novel, non-invasive approach based on trans-spinal direct current stimulation (tsDCS) to the treatment of patients with neuromotor and autonomic disorders.

Cytrellis Biosystems is a clinical stage medical technology company developing a new and proprietary class of aesthetic devices. This revolutionary technology for skin removal without invasive surgery or scarring addresses a very large unmet need in the areas of anti-aging, skin rejuvenation and body shaping.

PathMaker Neurosystems is a clinical stage neuromodulation company applying a fundamentally novel, non-invasive approach based on trans-spinal direct current stimulation (tsDCS) to the treatment of patients with neuromotor and autonomic disorders.

Directional Healthcare provides expertise and leadership in defining and commercializing new medical technologies. DHA's strengths are in launching and optimizing new products, bringing them from development to clinical practice.

Corindus Vascular Robotics is an NYSE listed public company (acquired by Siemens, 2019) and is the global technology leader in robotic-assisted vascular interventions. The company's CorPath System is the first robotic system that offers interventional cardiologists precise procedure and stent control during vascular interventions.

Medica designs, develops and manufactures in-vitro diagnostic analyzers highly regarded for ease of use, ease of maintenance and economy of operation.

Philips Cardiac Care develops and manufactures Advanced Life Support monitor defibrillators for resuscitating patients suffering cardiac arrest.

Project Engineer for transesophageal (TEE) ultrasound probes for echocardiography.